GTCR acquires Zentiva, a top European generics pharmaceutical company, from Advent
Experts involved in the Deal
Corporate Law, Mergers & Acquisitions
- Sébastien Binard
- Etienne Barthel
- Pierandrea Caligiuri
- Arnaud Quenette
- Alessandro Berardi
Finance & Capital Markets
- Lynn Alzin
- Alexandra Puszczynski
Tax
- Jan Neugebauer
- Arnaud Bruneton
- Marie Ange Akpoue
Employment Law, Pensions & Benefits
- Philippe Schmit
- Lorraine Chéry
- Paul Codazzi
IP, Communication & Technology
- Astrid Wagner
- Julien Pétré
- Tristan Vaisière
EU Financial & Competition Law
- Philippe-Emmanuel Partsch
- Ursula Bassoukou
- Achet-Billa Saleh
Arendt advised GTCR on the Luxembourg law aspects of its acquisition of Zentiva from Advent International. With a transaction value of approximately €4.1 billion, the deal stands out as one of the largest private equity transactions in the European healthcare and life sciences sector in 2025.
Contacts
Sébastien Binard
Partner
Etienne Barthel
Senior Associate
Lynn Alzin
Partner
Alexandra Puszczynski
Senior Associate
Jan Neugebauer
Partner
Arnaud Bruneton
Senior Associate
Philippe Schmit
Partner
Lorraine Chéry
Counsel
Astrid Wagner
Partner